Buy GLP-1 (SMA) 20mg Research Peptide OnlineGLP-1 (SMA) 20mg Product Specifications & StorageGLP-1 Receptor Agonist Analog (SMA) is a 31-amino-acid synthetic peptide incorporating strategic molecular modifications to improve bioavailability and pharmacological duration in preclinical research settings. The SMA designation reflects structural enhancements that differentiate this compound from native GLP-1 through enhanced proteolytic stability and extended receptor engagement in non-human model systems.GLP-1 (SMA) Mechanism of ActionMolecular modifications include site-specific amino acid substitutions and fatty acid conjugation that reduce DPP-4-mediated degradation while maintaining full agonist capacity at GLP-1 receptors. Preclinical pharmacokinetic studies demonstrate that these alterations extend active drug half-life significantly compared to unmodified GLP-1. Cell-based assays confirm that GLP-1 (SMA) exhibits full functional equivalence to native GLP-1 in receptor binding, G-protein coupling, and downstream signaling cascade activation at therapeutically relevant concentrations.GLP-1 (SMA) Published Research SummaryAnimal model research by Drucker and colleagues (2006) established the preclinical efficacy profile of extended-activity GLP-1 analogs, documenting consistent metabolic responses across multiple dosing regimens. In vivo studies demonstrate GLP-1 (SMA)-dependent modulation of glucose homeostasis through combined effects on insulin secretion, glucagon suppression, and gastric motility. Preclinical research further characterizes central nervous system penetration and hypothalamic GLP-1R signaling following systemic administration in laboratory animals.GLP-1 (SMA) 20mg is supplied as lyophilized powder for research applications. Reconstitute with sterile water or bacteriostatic saline; reconstituted solutions maintain stability for up to 48 hours at 4°C. Unreconstituted powder exhibits excellent shelf-life when stored at 2-8°C. Proper aseptic technique and storage temperature maintenance ensure consistent peptide quality throughout the research timeline.This product is restricted exclusively to preclinical research and laboratory investigation. It is not approved for human use, clinical administration, or therapeutic purposes. All applications must comply with institutional guidelines and regulatory requirements governing synthetic peptide research.
